Citadel Advisors’s G Medical Innovations Holdings Ltd. Warrants GMVDW Stock Holding History

Citadel Advisors’s Portfolio GMVDW Stock Details GMVDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-14,365	Closed	-$45.1K	–	15520
2023 Q2	$45.1K	Buy	+14,365	New	+$23.7K	﹤0.01%	11923

Citadel Advisors's GMVDW Position: Q3 2023 in Review

Citadel Advisors sold out of G Medical Innovations Holdings Ltd. Warrants (GMVDW) in Q3 2023, closing a stake of 14,365 shares — an estimated $45.1K sold.

Citadel Advisors first reported a position in GMVDW in Q2 2023 and held it in 1 quarter. The position peaked at $45.1K in Q2 2023. 0 funds tracked by Wall St. Rank hold GMVDW as of Q3 2023.

Citadel Advisors reported no remaining G Medical Innovations Holdings Ltd. Warrants position as of Q3 2023 after selling out during the quarter.
Citadel Advisors sold 14,365 G Medical Innovations Holdings Ltd. Warrants shares in Q3 2023, an estimated $45.1K.
Citadel Advisors first reported a position in G Medical Innovations Holdings Ltd. Warrants in Q2 2023 and held it in 1 quarter.
Citadel Advisors's G Medical Innovations Holdings Ltd. Warrants position peaked at $45.1K in Q2 2023.
0 funds tracked by Wall St. Rank held G Medical Innovations Holdings Ltd. Warrants as of Q3 2023.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.